Uncommon (formerly Higher Steaks), a UK-based cultivated meat company, has raised USD 30 million in Series A funding. The round was led by Balderton Capital and Lower Carbon Capital, with participation from Redalpine, East Alpha, and previous investors Max and Sam Altman, Miray Zaki, and Sebastiano Castiglioni.
The funds will help develop its innovative approach, expand production at its pilot manufacturing facility in Cambridge Technopark, hire additional talent, and initiate regulatory approvals.
The company leverages cell ag and RNA technologies to cultivate meat for the pork market. Uncommon's RNA technology offers advantages in cost, quality, and scalability.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.